Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRB-101 for Weight Maintenance in Obesity
NCT07553299Phase 2Terminated
- Start
- Jun 2026
- Primary completion
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ecnoglutide in obesity. Started Jun 2026; status: terminated.
02
Drugs
ecnoglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07553299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553299.